Ranbaxy, Pfizer settle Lipitor patent disputes (Reuters via Yahoo! News)
Ranbaxy, Pfizer settle Lipitor patent disputes (Reuters via Yahoo! News)
India’s Ranbaxy Laboratories has settled most of its patent disputes with Pfizer , allowing it to launch a generic version of the U.S. group’s blockbuster cholesterol drug Lipitor from November 30, 2011.